iRhythm Technologies, Inc.

NASDAQ:IRTC

Medical - Devices

Healthcare
$94.87 +0.35%

+$0.36 today

Market cap
$3.19B
Beta
1.28
P/E (TTM)
-119.5
EPS (TTM)
-$0.85
52W Low $100.85High $212.00

Volume 1.20M

Average 0.52M

IRTC Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

iRhythm Technologies, Inc.NASDAQ: IRTC

Accounts Receivables · Q3 FY2026 · quarter ended Sep 2026

Accounts receivables growth accelerates

Q3 FY2026 accounts receivables of $23.55M (cash outflow) rose 21.0% year over year, ahead of the +9.0% change in trailing-twelve-month accounts receivables. Sequentially, it fell 28.6% from the prior quarter. Over 3 fiscal years it compounded at +15.6% a year.

Context

  • Accounts receivables amounted to 12.8% of revenue in FY2025, down 2.8 pp from a year earlier.
  • Accounts receivables grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +21.0% holds above the trailing-twelve-month pace of +9.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$23.55M-28.6% QoQ
Last fiscal yearDec 2025
-$95.43M+3.8% YoY
LTMSep 2026
-$108.59M+9.0% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+21.0%——
1 year+3.8%——
3-year CAGR+15.6%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(95.43M) USD
Year-over-year change
-3.8%

Accounts Receivables vs competitors

How IRTC compares with its peers on the latest reported figures

  • IRTC's LTM Sep 2026 accounts receivables of $108.59M is the 3rd largest of the 7 companies compared; the peer median is $22.55M.
  • Its year-over-year change of +9.0% is the 5th highest of 7, against a peer median of +41.4%.
  • Accounts receivables amounts to 12.7% of revenue for IRTC, versus a peer median of 1.6%.
IRTC Competitors Peer median
Accounts Receivables for IRTC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BSXBoston Scientific CorporationLTM Jun 2026$293M +144.2%+6.9%1.4%
MDTMedtronic plcLTM Jul 2026$264M +3.5%-29.7%0.7%
IRTCiRhythm Technologies, Inc.LTM Sep 2026$108.59M +9.0%+15.6%12.7%
LIVNLivaNova PLCLTM Sep 2026$27.33M +124.1%+30.6%1.8%
PENPenumbra, Inc.LTM Jun 2026$17.77M -172.9%-34.6%1.2%
ATRCAtriCure, Inc.LTM Jun 2026$14.55M +45.3%-14.5%2.6%
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026$8.99M +37.6%—10.7%
Peer median (excluding IRTC) $22.55M+41.4%-14.5%1.6%

Competitors are the stored peer set for IRTC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(101.36M)(116.16M)(123.41M)(113.29M)(44.55M)
Depreciation & Amortization16.59M19.61M22.14M25.78M26.48M
Deferred Income Tax00000
Stock-Based Compensation54.53M57.74M77.2M75.98M88.28M
Change in Working Capital(46.23M)(65.51M)(102.05M)(99.12M)(91.7M)
Accounts Receivables(53.57M)(61.84M)(81.19M)(91.92M)(95.43M)
Inventory(4.96M)(5.11M)979K(224K)(8.51M)
Accounts Payables6.14M(2.99M)(1.97M)028.04M
Other Working Capital6.17M4.43M(19.86M)(6.97M)(15.8M)
Other Non-Cash Items38.72M81.3M76M114.04M102.35M
Operating Cash Flow(37.75M)(23.01M)(50.1M)3.39M80.86M
Capital Expenditures(28.07M)(29.83M)(40.42M)(48.94M)(46.34M)
Acquisitions (Net)00000
Purchases of Investments(122.18M)(188.57M)(167.29M)(175.24M)(468.41M)
Sales of Investments255.52M165.97M206.5M101.2M237.7M
Other Investing Activities000(15M)0
Investing Cash Flow105.26M(52.43M)(1.21M)(122.98M)(277.06M)
Debt Repayment(11.67M)13.53M0619.84M0
Common Stock Issued8.94M008.47M12.61M
Common Stock Repurchased000(25M)0
Dividends Paid00000
Other Financing Activities(25.85M)13.18M8.82M(91.93M)0
Financing Cash Flow(28.58M)26.72M8.82M511.38M12.61M
Effect of Forex Changes00(169K)(6K)1K
Net Change in Cash38.93M(48.73M)(42.66M)391.78M(183.59M)
Free Cash Flow(65.82M)(52.84M)(90.53M)(45.55M)34.52M

iRhythm Technologies, Inc.

NASDAQ:IRTC

Intrinsic Alpha fair value

Locked

Current Price

$94.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.